Immunoprofiling Correlates of Protection Against SHIV Infection in Adjuvanted HIV-1 Pox-Protein Vaccinated Rhesus Macaques

Human immunodeficiency virus type 1 (HIV-1) infection remains a major public health threat due to its incurable nature and the lack of a highly efficacious vaccine. The RV144 vaccine trial is the only clinical study to date that demonstrated significant but modest decrease in HIV infection risk. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Pinyi, Guerin, Dylan J., Lin, Shu, Chaudhury, Sidhartha, Ackerman, Margaret E., Bolton, Diane L., Wallqvist, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144500/
https://www.ncbi.nlm.nih.gov/pubmed/34046030
http://dx.doi.org/10.3389/fimmu.2021.625030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144500/
https://www.ncbi.nlm.nih.gov/pubmed/34046030
http://dx.doi.org/10.3389/fimmu.2021.625030

Ejemplares similares